Gene · 3037
HAS2: hyaluronan synthase 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. HAS2: hyaluronan synthase 2. Genes, record 3037. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3037
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q92819 | Hyaluronan synthase 2 | 552 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents69
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 49461 | Q92819 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4460 | Q92819 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1910 | Q92819 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1910 | Q92819 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4460 | Q92819 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 29486 | Q92819 | Espacenet |
| JP 2025013347 A | 2025-01-24 | 155 | Q92819 | Espacenet |
| US 12201675 B2 | 2025-01-21 | 155 | Q92819 | Espacenet |
| JP 2025003953 A | 2025-01-14 | 155 | Q92819 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 29486 | Q92819 | Espacenet |
1 to 10 of 69
See all 69 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,467
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HAS2 papers | Newest fiscal year |
|---|---|---|---|
| R01DK085252 | Extracellular Matrix Regulates Hepatic Stellate Cell Activation and Fibrosis | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 6 | 2025 |
| P30CA077598 | Cancer Center Support Grant | 5 | 2025 |
| P30EY007551 | Center Core Grant for Vision Research | 5 | 2025 |
| ZIAES102605 | The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury | 5 | 2025 |
| P01AG047200 | Comparative genomics of longevity and Alzheimer's disease | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 4 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 4 | 2025 |
| P30CA142543 | UT Southwestern Medical Center Simmons Comprehensive Cancer Center | 4 | 2025 |
1 to 10 of 1,467Source NIH's project files
See all 1,467 nih grantsPapers2,533
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 5-oxoproline supplementation enhances maturation and developmental competence of low-quality porcine cumulus-oocyte complexes during in vitro maturation. | Theriogenology | 2027 | 42748792 | PubTator, text mining | PubMed |
| In Vitro and Clinical Dermatological Effects of Rubus crataegifolius Fruit Extracts on Human Fibroblasts and Keratinocytes. | Pharmaceuticals (Basel) | 2026 | 42797496 | PubTator, text mining | PubMed |
| Effect of Prostaglandin Analogues on Hyaluronan Production of Orbital Fibroblasts. | Biomedicines | 2026 | 42792868 | PubTator, text mining | PubMed |
| Integrative network toxicology and transcriptomic analyses identify DCP1B and HAS2 as key prognostic biomarkers in formaldehyde-associated Wilms tumor. | J Int Med Res | 2026 | 42770314 | PubTator, text mining | PubMed |
| YAP1 Is Associated with Cumulus Expansion-Related Factor Expression and Autophagy-Related Signaling in Yak Cumulus Cells. | Animals (Basel) | 2026 | 42738425 | PubTator, text mining | PubMed |
| Exploring the influence of lactoferrin on wound healing and related signaling pathways: a systematic review. | FEBS Open Bio | 2026 | 42713832 | PubTator, text mining | PubMed |
| Genomic Landscape of Systemic Lupus Erythematosus and Lupus Nephritis Globally and the Gaps in Africa. | Int J Mol Sci | 2026 | 42653386 | PubTator, text mining | PubMed |
| LTBP4 deficiency induces MRC1+/CD44+ macrophages to drive cancer progression in preclinical colorectal cancer models. | Sci Transl Med | 2026 | 42647596 | PubTator, text mining | PubMed |
| Integrative transcriptomic and single-cell analysis identifies anoikis-related molecular signatures in vascular calcification. | Ren Fail | 2026 | 42634887 | PubTator, text mining | PubMed |
| Hyaluronan deficiency disrupts endothelial glycocalyx integrity and contributes to age-related arterial dysfunction. | Geroscience | 2026 | 42625099 | PubTator, text mining | PubMed |
1 to 10 of 2,533
See all 2,533 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3037
GET https://conductscience.org/api/genes/v1/3037/patents?page=2